Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| The B Group, Inc. | Institution | 11.414.285 | 6,58% | US$ 20,55M | 2026-03-31 |
| Janus Henderson Group plc | Institution | 10.689.452 | 6,16% | US$ 19,24M | 2026-03-31 |
| Octagon Capital Advisors LP | Institution | 10.276.317 | 5,92% | US$ 18,50M | 2026-03-31 |
| Octagon Investments Master Fund LP | Institution | 9.567.898 | 5,51% | US$ 17,22M | 2025-12-31 |
| Soleus Capital Master Fund, L.P. | Institution | 9.353.687 | 5,39% | US$ 16,84M | 2026-05-26 |
| Soleus Capital Management, L.P. | Institution | 9.353.687 | 5,39% | US$ 16,84M | 2026-05-26 |
| Commodore Capital Master LP | Institution | 9.332.443 | 5,38% | US$ 16,80M | 2025-10-01 |
| Perceptive Advisors LLC | Institution | 8.928.149 | 5,14% | US$ 16,07M | 2026-03-31 |
| Janus Henderson Biotech Innovation Master Fund Limited | Institution | 8.897.507 | 5,13% | US$ 16,02M | 2025-11-28 |
| Columbia Management Investment Advisers, LLC | Institution | 8.711.385 | 5,02% | US$ 15,68M | 2026-03-31 |
| Commodore Capital LP | Institution | 7.181.062 | 4,14% | US$ 12,93M | 2026-03-31 |
| RA Capital Management, L.P. | Institution | 7.124.116 | 4,10% | US$ 12,82M | 2026-03-31 |
| RA Capital Healthcare Fund, L.P. | Institution | 7.124.116 | 4,10% | US$ 12,82M | 2025-12-31 |
| Franklin Resources, Inc. | Institution | 5.785.189 | 3,33% | US$ 10,41M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 5.373.951 | 3,10% | US$ 9,67M | 2026-03-31 |
| Eversept Partners, L.P. | Institution | 4.987.499 | 2,87% | US$ 8,98M | 2026-03-31 |
| Boxer Capital Management, LLC | Institution | 4.799.875 | 2,77% | US$ 8,64M | 2026-03-31 |
| Morgan Stanley | Institution | 4.551.533 | 2,62% | US$ 8,19M | 2026-03-31 |
| Adage Capital Management, L.P. | Institution | 4.500.000 | 2,59% | US$ 8,10M | 2026-03-31 |
| Squadron Master Fund LP | Institution | 4.500.000 | 2,59% | US$ 8,10M | 2025-12-31 |
| Great Point Partners, LLC | Institution | 3.405.757 | 1,96% | US$ 6,13M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 3.270.845 | 1,88% | US$ 5,89M | 2026-03-31 |
| Federated Hermes, Inc. | Institution | 3.136.607 | 1,81% | US$ 5,65M | 2026-03-31 |
| Squadron Capital Management Llc | Institution | 3.000.000 | 1,73% | US$ 5,40M | 2026-03-31 |
| Wellington Management Group LLP | Institution | 2.904.911 | 1,67% | US$ 5,23M | 2026-03-31 |
| Marshall Wace LLP | Institution | 2.754.403 | 1,59% | US$ 4,96M | 2026-03-31 |
| Vestal Point Capital, LP | Institution | 2.500.000 | 1,44% | US$ 4,50M | 2026-03-31 |
| OrbiMed Advisors LLC | Institution | 2.333.000 | 1,34% | US$ 4,20M | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 2.264.845 | 1,30% | US$ 4,08M | 2026-03-31 |
| Millennium Management LLC | Institution | 2.103.353 | 1,21% | US$ 3,79M | 2026-03-31 |
| HighVista Strategies LLC | Institution | 2.019.326 | 1,16% | US$ 3,63M | 2026-03-31 |
| Artia Global Partners LP | Institution | 1.992.367 | 1,15% | US$ 3,59M | 2026-03-31 |
| BlackRock, Inc. | Institution | 1.876.340 | 1,08% | US$ 3,38M | 2026-03-31 |
| Sphera Funds Management Ltd | Institution | 1.733.471 | 1,00% | US$ 3,12M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1.546.240 | 0,89% | US$ 2,78M | 2026-03-31 |
| Renaissance Technologies LLC | Institution | 1.454.400 | 0,84% | US$ 2,62M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 1.429.308 | 0,82% | US$ 2,57M | 2026-03-31 |
| L1 Group Limited | Institution | 1.231.414 | 0,71% | US$ 2,22M | 2026-03-31 |
| UBS Asset Management AG | Institution | 1.166.951 | 0,67% | US$ 2,10M | 2026-03-31 |
| Propel Bio Management, LLC | Institution | 765.000 | 0,44% | US$ 1,38M | 2026-03-31 |
| Aberdeen Group Plc | Institution | 662.900 | 0,38% | US$ 1,19M | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 659.289 | 0,38% | US$ 1,19M | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
